These results were further confirmed by biodistribution analysis that showed that AT13387 significantly reduced EGFR expression in tumours with high expression and tumours with low expression (Fig. 4), and in ex vivo immunohistochemistry stainings (Fig. 5). Here, EGFR is linked to neoplasm.